InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,634.80
(
0.80%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.84
(
-0.09%
)
Bitcoin
60,094.19
(
-0.11%
)
Post# of 252477
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DFRAI post# 211743

Wednesday, 06/07/2017 10:19:35 PM

Wednesday, June 07, 2017 10:19:35 PM

Post# of 252477
>>TRIL

I assume they are paying for the nivo themselves and didn't want to get locked into one drug by having the owner pay (as has been fairly common in other combo trials). I also assume they chose the company who is most likely to want to partner if the results are good.

Be interesting to see what cohorts get expanded - I assume rituxan combo is one of them.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up